succinylacetone has been researched along with Central Nervous System Disease in 1 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruneau, N | 1 |
| St-Vil, D | 1 |
| Luks, FI | 1 |
| LaBerge, JM | 1 |
| Bensoussan, AL | 1 |
| Blanchard, H | 1 |
1 other study available for succinylacetone and Central Nervous System Disease
| Article | Year |
|---|---|
[Surgical and metabolic aspects of liver transplantation for tyrosinemia].
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Aminolevulinic Acid; Central Nervous System Diseas | 1993 |